Patient safety sets the foundation for a safe, equitable, trustworthy care experience — regardless of whether you’re ...

Teladoc (TDOC) shares are inching up after Citron Research likened them to a “coiled spring” – full of potential, compressed, ...

Teladoc Health Inc. failed to convince a federal judge Wednesday to toss most claims that the telehealth provider improperly ...

I maintain my Buy rating on Teladoc Health due to positive acquisitions and a robust balance sheet, despite recent weak Q1 ...

Following a sharp rally in the previous session, Teladoc Health (NYSE:TDOC) added ~5% in the premarket on Tuesday after ...

Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its ...

Teladoc Health stock price surged by over 14% on Monday, its best single-day gain since April 9. What next for the TDOC share ...

At the Goldman Sachs Annual Global Healthcare Conference in Miami, Teladoc CEO Chuck Divita laid out the virtual care giant’s strategy under his leadership after taking a year to do a dee | “We're ...

In the latest close session, Teladoc (TDOC) was up +2.33% at $7.02. This move outpaced the S&P 500's daily gain of 0.94%. On ...

Teladoc (NYSE: TDOC), a telemedicine specialist, was a little-known but rising star in its niche. Teladoc thrived during much of the pandemic, but the company's financial results and stock price ...

Summary. Teladoc Health, Inc.'s stock has declined significantly, from a high of $14 per share in February to $7 per share, with ongoing financial struggles and underperformance in key segments.